The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Are we getting any better at staying better? The long view on relapse and recovery in first episode nonaffective psychosis and schizophrenia
Open accessAbstract
Relapse in, and recovery from, schizophrenia has been acknowledged since the disease was first described. In this review the authors summarize the long-term (>100 years) data on relapse and recovery in schizophrenia by reviewing the extant older and modern relevant literature. The authors systematically question the utility of pharmacological and nonpharmacological interventions, with an emphasis on first episode nonaffective psychosis. The method used is a narrative review of earlier meta-analytic and systematic reviews. Antipsychotic medication discontinuation studies suggest a role for prophylactic maintenance treatment in the majority of people with schizophrenia, despite recent debate on this subject. The authors conclude that long-term outcomes, including relapse and recovery rates, have improved in the last 100 years, though prospectively identifying those people who do not require long-term antipsychotic treatment has not yet been possible. Data also suggests that interventions and outcomes during the first 5 years of the disease can influence the long-term schizophrenia trajectory.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Finally, neurobehavioural disorders tend to be chronic and relapse even after a positive response to treatment in the short term.20,21”
From Precision clinical trials: a framework for getting to precision medicine for neurobehavioural disorders (2021) · cites this paper as [20]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Remission in Schizophrenia: Proposed Criteria and Rationale for Consensus
Andreasen, N. C., Carpenter, W. T., Kane, J. M., Lasser, R. A., Marder, S. R., & Weinberger, D. R. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.3.441 · Cited by 2,343
A Meta-Analysis of Cognitive Remediation for Schizophrenia: Methodology and Effect Sizes
Wykes, T., Huddy, V., Cellard, C., McGurk, S. R., & Czobor, P. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10060855 · Cited by 1,693
Howes, O. D., McCutcheon, R., Agid, O., de Bartolomeis, A., van Beveren, N. J. M., Birnbaum, M. L., Bloomfield, M. A. P., Bressan, R. A., Buchanan, R. W., Carpenter, W. T., et al. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.16050503 · Cited by 1,132
Recovery from psychotic illness: A 15- and 25-year international follow-up study
Harrison, G., Hopper, K., Craig, T., Laska, E., Siegel, C., Wanderling, J., Dube, K. C., Ganev, K., Giel, R., Der Heiden, W. A., et al. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.178.6.506 · Cited by 1,030
Howes, O. D., Kambeitz, J., Kim, E., Stahl, D., Slifstein, M., Abi-Dargham, A., & Kapur, S. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2012.169 · Cited by 967
Leucht, S., Tardy, M., Komossa, K., Heres, S., Kissling, W., Salanti, G., & Davis, J. M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60239-6 · Cited by 931
A Systematic Review and Meta-Analysis of Recovery in Schizophrenia
Jaaskelainen, E., Juola, P., Hirvonen, N., McGrath, J. J., Saha, S., Isohanni, M., Veijola, J., & Miettunen, J. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs130 · Cited by 907
Review: Suicide and schizophrenia: a systematic review of rates and risk factors
Hor, K., & Taylor, M. (2010) · Journal of Psychopharmacology · doi:10.1177/1359786810385490 · Cited by 853
Self-citationCorrell, C. U., Galling, B., Pawar, A., Krivko, A., Bonetto, C., Ruggeri, M., Craig, T. J., Nordentoft, M., Srihari, V. H., Guloksuz, S., et al. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.0623 · Cited by 826
Neuroleptics and the Natural Course of Schizophrenia
Wyatt, R. J. (1991) · Schizophrenia Bulletin · doi:10.1093/schbul/17.2.325 · Cited by 787
Research works printed but not linked: 3
- Kraepelin E., 1987, Dementia praecox
- Hegarty JD, 1994, Am J Psychiatry, 151
- Takeuchi H, 2017, Schizophr Bull, 43, 862
Cited by
Sampogna, G., Vincenzo, M. D., Giuliani, L., Menculini, G., Mancuso, E., Arsenio, E., Cipolla, S., Rocca, B. D., Martiadis, V., Signorelli, M. S., et al. (2023) · Brain Sciences · doi:10.3390/brainsci13111577 · Cited by 82
New Developments in the Treatment of Schizophrenia: An Expert Roundtable
Kantrowitz, J. T., Correll, C. U., Jain, R., & Cutler, A. J. (2023) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyad011 · Cited by 57
Lin, D., Joshi, K., Keenan, A., Shepherd, J., Bailey, H. M. L., Berry, M., Wright, J., Meakin, S., Benson, C. J., & Kim, E. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.695672 · Cited by 49
Prevalence of treatment resistance and clozapine use in early intervention services
Stokes, I., Griffiths, S. L., Jones, R., Everard, L., Jones, P. B., Fowler, D. G., Hodgekins, J., Amos, T., Freemantle, N., Sharma, V. K., et al. (2020) · BJPsych Open · doi:10.1192/bjo.2020.89 · Cited by 44
Lenze, E. J., Nicol, G. E., Barbour, D. L., Kannampallil, T., Wong, A. W. K., Piccirillo, J., Drysdale, A. T., Sylvester, C. M., Haddad, R., Miller, J. P., et al. (2021) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.200042 · Cited by 43
Metadata
- Authors
- Taylor, M., & Jauhar, S.
- Affiliations
- The University of Queensland (AU)
- King's College London (GB)
- Corresponding author
- Taylor, Mark
- Venue
- Therapeutic Advances in Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2019-01
- Volume
- 9
- Pages
- 2045125319870033-2045125319870033
- ISSN
- 2045-1253 (ISSN-L)
- 2045-1261
- PMC
- PMC6732843
- OpenAlex
- W2971922960
- Cited by
- 51
- References
- 62
- Citations by year
- 2026: 8 · 2025: 5 · 2024: 8 · 2023: 6 · 2022: 9 · 2021: 10 · 2020: 4 · 2019: 1
- FWCI
- 1.01
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Therapeutic Advances in Psychopharmacology (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Research Portal (King's College London) (publishedVersion, cc-by-nc)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Keywords
- schizophrenia, first-episode psychosis, relapse, recovery, long-term outcomes, antipsychotic drugs, antipsychotic discontinuation, non-affective psychosis, treatment outcomes over time
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Are we getting any better at staying better? The long view on relapse and recovery in first episode nonaffective psychosis and schizophrenia. https://app.cochat.ai/papers/10.1177/2045125319870033
- The paper
- Taylor, M., & Jauhar, S. (2019). Are we getting any better at staying better? The long view on relapse and recovery in first episode nonaffective psychosis and schizophrenia. Therapeutic Advances in Psychopharmacology. https://doi.org/10.1177/2045125319870033
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.